References
- Armstrong M. D., Shaw K. N. F., Wall P. E. The phenolic acids of human urine. J. biol. Chem. 1956; 218: 293
- Carlsson A., Lindqvist M. In vivo decarboxylations of alpha-methyldopa and alpha-methyl metatyrosine. Acta physiol. scand. 1962; 54: 87, (Sweden)
- Day M. D., Rand M. J. A hypothesis for the mode of action of α-methyldopa in relieving hypertension. J. Pharm. Pharmacol. 1963; 15: 221
- Gillespie L., Jr, Oates J. A., Crout J. R., Sjoerdsma A. Clinical and chemical studies with alpha-methyldopa in patients with hypertension. Circulation 1962; 25: 281
- Gjessing L. R. Studies of functional neural tumors. 1. Urinary 3-methoxy-4-hydroxy-phenyl-metabolites. Scand. J. clin. Lab. Invest. 1963; 15: 463
- Gjessing L. R. Studies of periodic catatonia I. The protein-bound iodine and the vanillyl-mandelic acid. J. psychiat. Res. 1964a; 2: 123
- Gjessing L. R. Studies in periodic catatonia II. The urinary excretion of phenolic amines and acids with and without loads of different drugs. J. psychiat. Res. 1964b; 2: 149
- Goldstein M., Contrera J. F. The substrate specificity of phenylamine-β-hydroxylase. J. biol. Chem. 237, No. 1962; 6: 1898
- Goodman L. S., Gilman A. The pharmacological basis of therapeutics2nd ed. Macmillan, New York 1955
- Hess S. M., Connamacher R. H., Ozaki M., Udenfriend S. The effects of alpha-methyl-dopa and alpha-methyl-meta-tyrosine on the metabolism of norepinephrine and serotonin in vivo. J. Pharmacol. exp. Ther. 1961; 134: 129
- Kakimoto Y., Armstrong M. D. The phenolic amines of human urine. J. biol. Chem. 1962; 237: 208
- Sourkes T. L. Inhibition of dihydroxyphenyl-alanine decarboxylase by derivatives of phenyl-alanine. Arch. Biochem. 1954; 51: 444